Concord Medical to Report Fourth Quarter and Full Year 2015 Financial Results on March 28, 2016

BEIJING, March 14, 2016 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it will release its financial results for the fourth quarter and full year of 2015 after the market closes on March 28, 2016.

Management will hold a conference call to discuss the results the following day, at 8:00 a.m. EDT on March 29, 2016 (8:00 p.m. in Beijing/Hong Kong on March 29, 2016).

The dial-in details for the live conference call are as follows:

U.S. Toll Free:

1 866 519 4004

International:

65 67135090

U.K. Toll Free:

08082346646

Hong Kong Toll Free:

800906601

China Local:

400-620-8038/800-819-0121

Passcode:

CCM

A replay of the conference call may be accessed by phone at the following numbers from 11:00 a.m. ETMarch 29, 2016 to 09:59 a.m. ETApril 8, 2016.

U.S. Toll Free:

1 855 452 5696

International:

61 2 8199 0299

Conference ID:

70861955

Additionally, a live and archived webcast of the conference call will be available on the investor relations section of the Company's website at: http://ir.concordmedical.com/

About Concord Medical

Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of September 30, 2015, the Company operated a network of 127 centers with 76 hospital partners that spanned 53 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. As part of its high-end cancer hospital development strategy and oversea business extension, the Company acquired Concord Cancer Hospital, a private hospital in Singapore in April, 2015. For more information, please see http://ir.concordmedical.com.